These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 37335630)
1. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma. Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630 [TBL] [Abstract][Full Text] [Related]
2. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma. Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269 [TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma. Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177 [TBL] [Abstract][Full Text] [Related]
6. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma. He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630 [TBL] [Abstract][Full Text] [Related]
7. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Chen L; Cai Z; Lyu K; Cai Z; Lei W Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440 [TBL] [Abstract][Full Text] [Related]
8. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma. Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294 [TBL] [Abstract][Full Text] [Related]
10. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma. Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142 [TBL] [Abstract][Full Text] [Related]
11. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
12. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA. Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. Guo YZ; Sun HH; Wang XT; Wang MT J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634 [TBL] [Abstract][Full Text] [Related]
14. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma. Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma. Ji L; Liang S; Cheng Y; Gao R; Yan W; Pang F; Zhang F Cancer Biomark; 2024; 40(3-4):319-342. PubMed ID: 39213052 [TBL] [Abstract][Full Text] [Related]
16. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
17. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
18. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors. Li H; Lv Z; Liu M Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111 [TBL] [Abstract][Full Text] [Related]
19. Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis. Lu R; Li Z; Yin S Biochem Genet; 2022 Oct; 60(5):1825-1844. PubMed ID: 35098409 [TBL] [Abstract][Full Text] [Related]
20. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma. Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]